Loading the section
The price of Vaxcyte, Inc. (PCVX) on October 9, 2026 is 71.38 USD, +9.79% on the day. Over 52 weeks the stock traded between 39.87 USD and 90.75 USD; the price now sits 62% of the way up that range. Over the past year the price changed by +75.21%. Market capitalization is 9.47 billion USD, rank 12 among 128 stocks of the same industry with a known capitalization.
Closing prices for 09 October 2026
Next earnings report: 03 November 2026 · Earnings calendar
Vaxcyte, Inc. trades on Nasdaq under the ticker PCVX. The company belongs to the Health care sector. The trading history on this page starts on 12 June 2020.
Over the past 52 weeks PCVX has traded between 39.87 $ and 90.75 $. As of 09 October 2026 the price stood 61.93 % of the way from the 52-week low to the high.
Over one year PCVX shares rose 75.21 %; over six months they rose 17.25 %. Volatility over 90 days is 63.45 %. Dividends are not included: this is price change only, as of 09 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to book is 3.2, above the sector median of 2.4. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 64.78 | 72.44 | 64.78 | 71.38 | 4M |
| 08 October 2026 | 67.14 | 67.97 | 63.79 | 65.02 | 4M |
| 07 October 2026 | 65.86 | 67.15 | 64.27 | 66.96 | 12M |
| 06 October 2026 | 73.35 | 73.40 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Vaxcyte, Inc. (PCVX) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2025-12-31, net income was -766.6m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Address:825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070, US
PCVX has a return on equity of −31.59 %, above the sector median of −41.68 %. Return on assets is −28.27 %, above the sector median of −32.11 %.
| 428M |
| RVMDRevolution Medicines, Inc. | 189.76 | +0.87 % | 409M |
| HALOHalozyme Therapeutics, Inc. | 111.70 | +1.69 % | 251M |
| BIIBBiogen Inc. | 226.01 | +3.47 % | 224M |
| TECHBio-Techne Corp | 72.46 | +0.01 % | 215M |
| 63.90 |
| 66.70 |
| 10M |
| 05 October 2026 | 87.21 | 90.75 | 71.60 | 73.82 | 15M |
| 02 October 2026 | 56.76 | 57.00 | 55.84 | 56.48 | 2M |
| 01 October 2026 | 56.73 | 57.17 | 56.00 | 56.05 | 1M |
| 30 September 2026 | 56.69 | 57.51 | 56.13 | 56.90 | 2M |
| 29 September 2026 | 57.96 | 58.98 | 55.91 | 56.69 | 1M |
| 28 September 2026 | 56.50 | 58.82 | 55.75 | 58.27 | 2M |
| 25 September 2026 | 57.22 | 57.50 | 55.92 | 56.21 | 947,300 |
| 24 September 2026 | 55.86 | 57.59 | 55.09 | 56.90 | 2M |
| 23 September 2026 | 59.02 | 59.10 | 55.09 | 56.50 | 2M |
| 22 September 2026 | 59.45 | 59.96 | 58.78 | 59.02 | 1M |
| 21 September 2026 | 59.00 | 60.54 | 57.62 | 58.92 | 1M |
| 18 September 2026 | 60.37 | 60.37 | 57.01 | 58.13 | 3M |
| 17 September 2026 | 60.22 | 61.50 | 59.31 | 60.37 | 1M |
| 16 September 2026 | 59.25 | 60.13 | 58.40 | 58.77 | 1M |
| 15 September 2026 | 59.70 | 59.75 | 58.19 | 59.21 | 2M |
| 14 September 2026 | 60.04 | 60.86 | 59.09 | 59.54 | 1M |